Drug Trial Radar · NCT07557407
A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects
Last checked: Nov 20, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
6
Planned (sponsor's estimate)
Start
May 2026
Primary completion
Jun 2026
Study completion Jun 2026
Sponsor
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 29, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study aims to evaluate the pharmacokinetics, mass balance recovery, metabolite profile and metabolite identification of \[14C\]HRS-1780 following an oral single dose in healthy adult male participants.
Conditions
- Chronic Kidney Diseases
Interventions
[14C]HRS-1780Drug
\[14C\]HRS-1780, oral.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total radioactivity ratio of whole blood/plasma.Time frame: 0 to anticipated 11 days.
- TmaxTime frame: 0 to anticipated 11 days.
- CmaxTime frame: 0 to anticipated 11 days.
- AUClastTime frame: 0 to anticipated 11 days.
- AUC0-infTime frame: 0 to anticipated 11 days.
- t1/2Time frame: 0 to anticipated 11 days.
- CL/FTime frame: 0 to anticipated 11 days.
- Vz/FTime frame: 0 to anticipated 11 days.
- %AUCTime frame: 0 to anticipated 11 days.
- %DoseTime frame: 0 to anticipated 11 days.
- Total radioactivity ratio for blood/plasma.Time frame: 0 to anticipated 11 days.
- The cumulative recovery amount and recovery rate of total radioactive substances in urine and feces.Time frame: 0 to anticipated 11 days.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Jinan Central Hospital, Affiliated to Shandong First Medical University
Jinan, Shandong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.